These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8589345)

  • 1. Role of Ito cells in the degradation of matrix in liver.
    Arthur MJ
    J Gastroenterol Hepatol; 1995; 10 Suppl 1():S57-62. PubMed ID: 8589345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of matrix proteins in liver fibrosis.
    Arthur MJ
    Pathol Res Pract; 1994 Oct; 190(9-10):825-33. PubMed ID: 7899131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.
    Benyon RC; Iredale JP; Goddard S; Winwood PJ; Arthur MJ
    Gastroenterology; 1996 Mar; 110(3):821-31. PubMed ID: 8608892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitors of metalloproteinases in liver fibrosis.
    Iredale JP
    Int J Biochem Cell Biol; 1997 Jan; 29(1):43-54. PubMed ID: 9076940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
    Arthur MJ; Mann DA; Iredale JP
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
    Arthur MJ
    Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G245-9. PubMed ID: 10915630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease.
    Arthur MJ; Iredale JP; Mann DA
    Alcohol Clin Exp Res; 1999 May; 23(5):940-3. PubMed ID: 10371419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
    Butler GS; Will H; Atkinson SJ; Murphy G
    Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix degradation and the role of hepatic stellate cells.
    Benyon RC; Arthur MJ
    Semin Liver Dis; 2001 Aug; 21(3):373-84. PubMed ID: 11586466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenases and liver fibrosis.
    Arthur MJ
    J Hepatol; 1995; 22(2 Suppl):43-8. PubMed ID: 7665849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
    Iredale JP; Benyon RC; Arthur MJ; Ferris WF; Alcolado R; Winwood PJ; Clark N; Murphy G
    Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis.
    McLaughlin B; Weiss JB
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):739-45. PubMed ID: 8760357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade.
    Thomson BM; Atkinson SJ; McGarrity AM; Hembry RM; Reynolds JJ; Meikle MC
    Biochim Biophys Acta; 1989 Nov; 1014(2):125-32. PubMed ID: 2554972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate.
    Brown CC; Hembry RM; Reynolds JJ
    J Bone Joint Surg Am; 1989 Apr; 71(4):580-93. PubMed ID: 2539384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP and TIMP expression pattern in pleural effusions of different origins.
    Eickelberg O; Sommerfeld CO; Wyser C; Tamm M; Reichenberger F; Bardin PG; Solèr M; Roth M; Perruchoud AP
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1987-92. PubMed ID: 9412584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic lipocytes, TIMP-1 and liver fibrosis.
    Arthur MJ; Iredale JP
    J R Coll Physicians Lond; 1994; 28(3):200-8. PubMed ID: 7932316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R; Toth M; Peña D; Mobashery S
    Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.
    McCrudden R; Iredale JP
    Histol Histopathol; 2000 Oct; 15(4):1159-68. PubMed ID: 11005241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.